Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ) has provided an update.
Jubilant Pharmova Limited’s Board of Directors has approved the grant of 1,506 Stock Options/Restricted Stock Units (RSUs) to eligible employees under the Jubilant Pharmova Employees Stock Option Plan 2018. This move is part of the company’s strategy to incentivize and retain talent, potentially impacting employee motivation and aligning their interests with the company’s long-term goals.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development, manufacture, and distribution of pharmaceutical products. The company is known for its wide range of products and services catering to various healthcare needs.
Average Trading Volume: 8,283
Technical Sentiment Signal: Buy
Current Market Cap: 178.3B INR
For an in-depth examination of JUBLPHARMA stock, go to TipRanks’ Overview page.